CA2944805C - Phenanthroline phosphonic acid derivative and preparation method therefor and application thereof - Google Patents

Phenanthroline phosphonic acid derivative and preparation method therefor and application thereof Download PDF

Info

Publication number
CA2944805C
CA2944805C CA2944805A CA2944805A CA2944805C CA 2944805 C CA2944805 C CA 2944805C CA 2944805 A CA2944805 A CA 2944805A CA 2944805 A CA2944805 A CA 2944805A CA 2944805 C CA2944805 C CA 2944805C
Authority
CA
Canada
Prior art keywords
compound
formula
acceptable salt
pharmaceutically acceptable
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2944805A
Other languages
English (en)
French (fr)
Other versions
CA2944805A1 (en
Inventor
Yue Zhu
Yuzhen LIAO
Li Zhang
Xu Bai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xiamen Beryl Therapeutics Inc
Original Assignee
Xiamen Beryl Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xiamen Beryl Therapeutics Inc filed Critical Xiamen Beryl Therapeutics Inc
Publication of CA2944805A1 publication Critical patent/CA2944805A1/en
Application granted granted Critical
Publication of CA2944805C publication Critical patent/CA2944805C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/60—Quinoline or hydrogenated quinoline ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574—Esters of oxyacids of phosphorus
    • C07F9/65742—Esters of oxyacids of phosphorus non-condensed with carbocyclic rings or heterocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/657163—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
    • C07F9/657181—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom the ring phosphorus atom and, at least, one ring oxygen atom being part of a (thio)phosphonic acid derivative

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA2944805A 2014-04-10 2015-04-10 Phenanthroline phosphonic acid derivative and preparation method therefor and application thereof Active CA2944805C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201410142608.8A CN104974187A (zh) 2014-04-10 2014-04-10 菲罗啉类衍生物及其制备方法和应用
CN201410142608.8 2014-04-10
PCT/CN2015/076273 WO2015154716A1 (zh) 2014-04-10 2015-04-10 菲罗啉膦酸类衍生物及其制备方法和应用

Publications (2)

Publication Number Publication Date
CA2944805A1 CA2944805A1 (en) 2015-10-15
CA2944805C true CA2944805C (en) 2022-11-29

Family

ID=54271195

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2944805A Active CA2944805C (en) 2014-04-10 2015-04-10 Phenanthroline phosphonic acid derivative and preparation method therefor and application thereof

Country Status (9)

Country Link
US (1) US10072035B2 (enExample)
EP (1) EP3130593B1 (enExample)
JP (1) JP6545254B2 (enExample)
KR (1) KR102369908B1 (enExample)
CN (2) CN104974187A (enExample)
CA (1) CA2944805C (enExample)
EA (1) EA030709B1 (enExample)
SG (1) SG11201608422VA (enExample)
WO (1) WO2015154716A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108863797B (zh) * 2018-07-02 2021-01-15 吉首大学 一类3-(取代/非取代苯基)-3-羟基丙酰氧肟酸的制备方法
CN114958927A (zh) * 2021-02-22 2022-08-30 尚科生物医药（上海）有限公司 一种制备(s)-1-(3-氯苯基)-1,3-丙二醇的方法
CN113072585B (zh) * 2021-04-02 2023-11-10 厦门市博瑞来医药科技有限公司 手性芳基膦酸环二酯及其衍生物的制备

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3524846A (en) 1967-06-02 1970-08-18 Syntex Corp Process for the didealkylation of phosphonate esters
US6011021A (en) * 1996-06-17 2000-01-04 Guilford Pharmaceuticals Inc. Methods of cancer treatment using naaladase inhibitors
ATE255581T1 (de) * 1997-10-24 2003-12-15 Fibrogen Inc Phenanthrolin-derivate
US5916898A (en) * 1997-10-24 1999-06-29 Zeneca Limited Phenanthroline derivatives
NZ555911A (en) * 2002-01-07 2008-07-31 Eisai R&D Man Co Ltd Deazapurines and uses thereof
JP2008527030A (ja) * 2005-01-19 2008-07-24 バイオリポックス エービー 炎症の治療に有用なインドール類
JP5362999B2 (ja) * 2008-01-30 2013-12-11 九州電力株式会社 有機ｅｌ素子およびジベンゾホスホールオキシド誘導体
JP5553275B2 (ja) 2010-03-31 2014-07-16 国立大学法人金沢大学 金属錯体およびこれを有効成分として含有する抗がん剤
US9326991B2 (en) 2012-09-14 2016-05-03 Ligand Pharmaceuticals, Inc. Nucleotide prodrug compounds and use

Also Published As

Publication number Publication date
EP3130593A1 (en) 2017-02-15
CN106661060B (zh) 2019-04-19
US20170029452A1 (en) 2017-02-02
US10072035B2 (en) 2018-09-11
CA2944805A1 (en) 2015-10-15
CN104974187A (zh) 2015-10-14
EP3130593B1 (en) 2020-09-23
EA030709B1 (ru) 2018-09-28
CN106661060A (zh) 2017-05-10
KR20160146791A (ko) 2016-12-21
SG11201608422VA (en) 2016-11-29
WO2015154716A1 (zh) 2015-10-15
JP6545254B2 (ja) 2019-07-17
EA201692045A1 (ru) 2017-05-31
EP3130593A4 (en) 2017-11-01
KR102369908B1 (ko) 2022-03-02
JP2017513934A (ja) 2017-06-01

Similar Documents

Publication Publication Date Title
JP6401771B2 (ja) ヘモグロビンの修飾のための化合物及びその使用
EP3157904B1 (en) Anti-infective compounds
WO2023062575A1 (en) Cyclic vinyl sulfone compounds as wrn inhibitors
CN112707905B (zh) 一种三并杂环化合物及其制备方法和用途
JP2020073466A (ja) プロドラッグ化合物およびそれらの使用
KR101760651B1 (ko) 피롤일 치환된 다이하이드로인돌 2 온 유도체, 그의 제조 방법 및 용도
JP2016516696A (ja) ヘモグロビンの修飾のための化合物及びその使用
JP2007291111A (ja) キナーゼインヒビターホスホネート抱合体
JP2007520452A (ja) ホスホネート誘導体としてのイノシン一リン酸デヒドロゲナーゼインヒビター
TWI324066B (en) A pharmaceutical composition for inhibiting cell migration induced by an angiogenic factor
AU2015215335B2 (en) Pyrrole-substituted indolone derivative, preparation method therefor, composition comprising same and use thereof
CA2944805C (en) Phenanthroline phosphonic acid derivative and preparation method therefor and application thereof
US10150788B2 (en) Prodrug compounds and uses thereof
JP2007500727A (ja) 抗ウイルス処置のための核酸塩基ホスホネートアナログ
JP2024073414A (ja) ゲムシタビン誘導体の新規小分子薬物コンジュゲート
Zhou et al. Structure-guided design of novel HEPT analogs with enhanced potency and safety: from isopropyl-HEPTs to cyclopropyl-HEPTs
KR20060028632A (ko) 항염증 포스포네이트 화합물
WO2007043568A1 (ja) Ｓ１ｐ３受容体拮抗剤
JP2017513934A5 (enExample)
CN118684666A (zh) Kif18a抑制剂及其用途
HK1231883B (zh) 菲罗啉膦酸类衍生物及其制备方法和应用
JP2025511253A (ja) オピカポンのプロドラッグ
HK1231883A1 (en) Phenanthroline phosphonic acid derivative and preparation method therefor and application thereof
CN108117551A (zh) 取代(1H-吡唑[3,4-b]吡啶)脲类化合物及其抗肿瘤用途
Chen Synthetic Studies Towards Water-Soluble Derivatives of PI-PLC Inhibiting Thieno [2, 3-b] pyridines

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20200309

EEER Examination request

Effective date: 20200309

EEER Examination request

Effective date: 20200309

EEER Examination request

Effective date: 20200309

EEER Examination request

Effective date: 20200309

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 10TH ANNIV.) - SMALL

Year of fee payment: 10

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250331

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250331